Mid Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Dr. Reddy's Laboratories
RDY
$9.96B
| $9.96B | $11.96 | 2.13% |
|
2
Alkermes
ALKS
$7.74B
| $7.74B | $46.14 | 0.07% |
|
3
Lantheus
LNTH
$6.56B
| $6.56B | $100.41 | 0.02% |
|
4
Hims & Hers Health
HIMS
$6.37B
| $6.37B | $27.31 | 0.47% |
|
5
Liquidia Corp
LQDA
$6.05B
| $6.05B | $67.60 | 0.37% |
|
6
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $5.99B | $76.72 | 0.31% |
|
7
Amneal Pharmaceuticals
AMRX
$5.9B
| $5.9B | $16.93 | 0.36% |
|
8
Indivior Pharmaceuticals
INDV
$4.05B
| $4.05B | $34.33 | 0.52% |
|
9
Amylyx Pharmaceuticals
AMLX
$3.55B
| $3.55B | $31.88 | 0.65% |
|
10
Regencell Bioscience
RGC
$2.81B
| $2.81B | $5.68 | 0.71% |
|
11
Supernus Pharmaceuticals
SUPN
$2.42B
| $2.42B | $41.65 | 0.1% |
|
12
Prestige Consumer Healthcare
PBH
$2.24B
| $2.24B | $47.30 | 0.08% |
|
13
HUTCHMED
HCM
$2.24B
| $2.24B | $12.86 | 1.98% |
|
14
Bausch Health
BHC
$2.23B
| $2.23B | $5.95 | 1.98% |
|
|
TRLV
15
Trulieve Cannabis Corp
TRLV
$2.18B
| $2.18B | $11.30 | 0.18% |
|
16
BioCryst Pharmaceuticals
BCRX
$2.09B
| $2.09B | $8.18 | 1.33% |
|
Mid Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 16 mid cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $2B and $10B — worth a combined $72.4B.
The largest by market cap are Dr. Reddy's Laboratories (RDY) at $9.96B, Alkermes (ALKS) at $7.74B and Lantheus (LNTH) at $6.56B.
Among institutional investors, Trulieve Cannabis Corp (TRLV) drew the most net new fund positions in Q2 2026: 121 funds opened new positions, taking total fund holders up 119 (1,983%) quarter-over-quarter.
- Combined market cap: $72.4B across 16 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Dr. Reddy's Laboratories (RDY), $9.96B market cap.
- Most net new fund positions in Q2 2026: Trulieve Cannabis Corp (TRLV), +119 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.